Data Breach Law Group Investigates the Glenmark Pharmaceuticals Inc USA Data Breach
By Data Breach Law Group | Posted on March 17, 2026 · Indiana
Miami, FL — Data Breach Law Group is investigating a data breach involving Glenmark Pharmaceuticals Inc USA, reported to the Indiana Attorney General on March 17, 2026. The firm is reviewing whether affected individuals have legal claims arising from the incident.
Glenmark Pharmaceuticals Inc USA is a global pharmaceutical company specializing in the research, development, and manufacturing of generic and specialty medications. As a healthcare-adjacent entity, the company routinely collects and maintains sensitive personal information, including patient health data, prescription records, and insurance details necessary for drug distribution and clinical support. In 2026, the company officially reported a data security incident to the Indiana Attorney General, confirming that unauthorized access to their systems occurred. If you received a data breach notification letter from Glenmark Pharmaceuticals, it indicates that your personal or health-related information may have been compromised. This notification is intended to inform you of the incident and provide guidance on the steps you should take to protect your identity and medical privacy.
If you were affected
Stay alert to targeted scams
Be cautious of calls, texts, or emails that reference this breach. Legitimate organizations won't ask you to confirm sensitive details through an unsolicited message.
Keep your notification letter
Save the notice you received. It documents that your information was involved and is often needed to enroll in any credit monitoring offered or to join a related legal claim.
Did you receive a letter from Glenmark Pharmaceuticals Inc USA?
A case review is free and confidential. Tell us about your letter and we will explain your options.